Clover Health Investments Gross Profit

The latest gross profit for CLOV is $2.1B as of June 2026. That compares with $580M in the prior-year period — up 261.7% year over year. That is below the Finance sector average of $720B. Investors often review this figure alongside Clover Health Investments's historical trend and sector peers before judging valuation or financial health.

Over the past year, CLOV's gross profit moved from $580M to $2.1B — a 261.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Clover Health Investments's operating scale or balance-sheet position.

Against Finance companies, CLOV currently prints $2.1B for gross profit, while the sector average sits near $720B. That is roughly 99.7% below the sector mean. Large gaps often invite a closer look at Clover Health Investments's growth, margins, and balance sheet.

A gross profit figure of $2.1B for CLOV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Finance average is about $720B. Explore the charts below for those layers of context.

After noting CLOV's gross profit ($2.1B), review year-over-year change from $580M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.